Glaucoma diagnostics and imaging technology represent a rapidly evolving area at the intersection of clinical ophthalmology, biomedical engineering, and ...

“Weight-loss methods, whether with pharmacotherapy or surgery, have to be mindful to avoid inducing these complications,” ...

Transthyretin amyloidosis (ATTR) is a rare, progressive and highly aggressive degenerative disease. It is caused by the ...

Research shows that heart disease is a long-recognized and persistent medical challenge for gorillas living in zoos, ...

Sarepta Therapeutics' gene ‌therapy for Duchenne muscular dystrophy slowed disease progression and showed sustained benefit ...

By determining the structure of the deposits responsible for transthyretin amyloidosis through a simple skin biopsy, scientists at UNIGE are paving the way for a new diagnostic method for ...

Shield’s FDA-approved blood test drives cancer screening growth, pricing power, and cash-flow upside. Click for this GH ...

A commercial partnership between Topcon Healthcare and RemoniHealth is integrating the latter’s home-based ocular disease ...

Batten disease is a rare inherited condition that affects brain development and function. CLN3 disease is the most common type of this disease. The symptoms are life changing. They usually begin ...

Objectives Current prediction models for disease progression to AIDS in people living with HIV primarily rely on traditional statistical methods. This study aimed to develop and compare four machine ...

A new ACC Concise Clinical Guidance (CCG) report on "Transthyretin Cardiac Amyloidosis Evaluation and Management" provides updated strategies and best practices for clinicians, taking into account ...

Regenerative medicine company Regeneus (ASX: RGS) has reached a significant milestone in its mission to market its proprietary biomarkers in China. The company is developing a portfolio of innovative ...